The global diabetes devices market size is calculated at USD 35.26 billion in 2025 and is projected to surpass around USD 68.75 billion by 2034, expanding at a CAGR of 7.7% from 2025 to 2034. The North America diabetes devices market size reached USD 13.75 billion in 2024 and is expanding at a CAGR of 7.74% during the forecast period. The market sizing and forecasts are revenue-based (USD Million/Billion), with 2024 as the base year.
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
3.1. Market Snapshot
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
5.1. Market Dynamics
5.1.1. Market Drivers
5.1.2. Market Restraints
5.1.3. Market Opportunities
5.2. Porter’s Five Forces Analysis
5.2.1. Bargaining power of suppliers
5.2.2. Bargaining power of buyers
5.2.3. Threat of substitute
5.2.4. Threat of new entrants
5.2.5. Degree of competition
6.1.1. Company Market Share/Positioning Analysis
6.1.2. Key Strategies Adopted by Players
6.1.3. Vendor Landscape
6.1.3.1. List of Suppliers
6.1.3.2. List of Buyers
7.1. Diabetes Devices Market, by Type,
7.1.1. Blood Glucose Monitoring
7.1.1.1. Market Revenue and Forecast
7.1.2. Insulin Delivery Devices
7.1.2.1. Market Revenue and Forecast
8.1. Diabetes Devices Market, by Application,
8.1.1. Diagnostic Center
8.1.1.1. Market Revenue and Forecast
8.1.2. Hospitals
8.1.2.1. Market Revenue and Forecast
8.1.3. Home Care
8.1.3.1. Market Revenue and Forecast
9.1. Diabetes Devices Market, by Distribution Channel,
9.1.1. Retail Pharmacy
9.1.1.1. Market Revenue and Forecast
9.1.2. Hospital Pharmacy
9.1.2.1. Market Revenue and Forecast
9.1.3. Clinics
9.1.3.1. Market Revenue and Forecast
9.1.4. Online Pharmacy
9.1.4.1. Market Revenue and Forecast
9.1.5. Others
9.1.5.1. Market Revenue and Forecast
10.1. North America
10.1.1. Market Revenue and Forecast, by Type
10.1.2. Market Revenue and Forecast, by Application
10.1.3. Market Revenue and Forecast, by Distribution Channel
10.1.4. U.S.
10.1.4.1. Market Revenue and Forecast, by Type
10.1.4.2. Market Revenue and Forecast, by Application
10.1.4.3. Market Revenue and Forecast, by Distribution Channel
10.1.5. Rest of North America
10.1.5.1. Market Revenue and Forecast, by Type
10.1.5.2. Market Revenue and Forecast, by Application
10.1.5.3. Market Revenue and Forecast, by Distribution Channel
10.2. Europe
10.2.1. Market Revenue and Forecast, by Type
10.2.2. Market Revenue and Forecast, by Application
10.2.3. Market Revenue and Forecast, by Distribution Channel
10.2.4. UK
10.2.4.1. Market Revenue and Forecast, by Type
10.2.4.2. Market Revenue and Forecast, by Application
10.2.4.3. Market Revenue and Forecast, by Distribution Channel
10.2.5. Germany
10.2.5.1. Market Revenue and Forecast, by Type
10.2.5.2. Market Revenue and Forecast, by Application
10.2.5.3. Market Revenue and Forecast, by Distribution Channel
10.2.6. France
10.2.6.1. Market Revenue and Forecast, by Type
10.2.6.2. Market Revenue and Forecast, by Application
10.2.6.3. Market Revenue and Forecast, by Distribution Channel
10.2.7. Rest of Europe
10.2.7.1. Market Revenue and Forecast, by Type
10.2.7.2. Market Revenue and Forecast, by Application
10.2.7.3. Market Revenue and Forecast, by Distribution Channel
10.3. APAC
10.3.1. Market Revenue and Forecast, by Type
10.3.2. Market Revenue and Forecast, by Application
10.3.3. Market Revenue and Forecast, by Distribution Channel
10.3.4. India
10.3.4.1. Market Revenue and Forecast, by Type
10.3.4.2. Market Revenue and Forecast, by Application
10.3.4.3. Market Revenue and Forecast, by Distribution Channel
10.3.5. China
10.3.5.1. Market Revenue and Forecast, by Type
10.3.5.2. Market Revenue and Forecast, by Application
10.3.5.3. Market Revenue and Forecast, by Distribution Channel
10.3.6. Japan
10.3.6.1. Market Revenue and Forecast, by Type
10.3.6.2. Market Revenue and Forecast, by Application
10.3.6.3. Market Revenue and Forecast, by Distribution Channel
10.3.7. Rest of APAC
10.3.7.1. Market Revenue and Forecast, by Type
10.3.7.2. Market Revenue and Forecast, by Application
10.3.7.3. Market Revenue and Forecast, by Distribution Channel
10.4. MEA
10.4.1. Market Revenue and Forecast, by Type
10.4.2. Market Revenue and Forecast, by Application
10.4.3. Market Revenue and Forecast, by Distribution Channel
10.4.4. GCC
10.4.4.1. Market Revenue and Forecast, by Type
10.4.4.2. Market Revenue and Forecast, by Application
10.4.4.3. Market Revenue and Forecast, by Distribution Channel
10.4.5. North Africa
10.4.5.1. Market Revenue and Forecast, by Type
10.4.5.2. Market Revenue and Forecast, by Application
10.4.5.3. Market Revenue and Forecast, by Distribution Channel
10.4.6. South Africa
10.4.6.1. Market Revenue and Forecast, by Type
10.4.6.2. Market Revenue and Forecast, by Application
10.4.6.3. Market Revenue and Forecast, by Distribution Channel
10.4.7. Rest of MEA
10.4.7.1. Market Revenue and Forecast, by Type
10.4.7.2. Market Revenue and Forecast, by Application
10.4.7.3. Market Revenue and Forecast, by Distribution Channel
10.5. Latin America
10.5.1. Market Revenue and Forecast, by Type
10.5.2. Market Revenue and Forecast, by Application
10.5.3. Market Revenue and Forecast, by Distribution Channel
10.5.4. Brazil
10.5.4.1. Market Revenue and Forecast, by Type
10.5.4.2. Market Revenue and Forecast, by Application
10.5.4.3. Market Revenue and Forecast, by Distribution Channel
10.5.5. Rest of LATAM
10.5.5.1. Market Revenue and Forecast, by Type
10.5.5.2. Market Revenue and Forecast, by Application
10.5.5.3. Market Revenue and Forecast, by Distribution Channel
11.1. B Braun Melsungen AG
11.1.1. Company Overview
11.1.2. Product Offerings
11.1.3. Financial Performance
11.1.4. Recent Initiatives
11.2. Abbott Laboratories
11.2.1. Company Overview
11.2.2. Product Offerings
11.2.3. Financial Performance
11.2.4. Recent Initiatives
11.3. Bayer AG
11.3.1. Company Overview
11.3.2. Product Offerings
11.3.3. Financial Performance
11.3.4. Recent Initiatives
11.4. Medtronic Plc
11.4.1. Company Overview
11.4.2. Product Offerings
11.4.3. Financial Performance
11.4.4. Recent Initiatives
11.5. F.Hoffman-La-Ltd.
11.5.1. Company Overview
11.5.2. Product Offerings
11.5.3. Financial Performance
11.5.4. Recent Initiatives
11.6. Lifescan, Inc.
11.6.1. Company Overview
11.6.2. Product Offerings
11.6.3. Financial Performance
11.6.4. Recent Initiatives
11.7. Dexcom, Inc.
11.7.1. Company Overview
11.7.2. Product Offerings
11.7.3. Financial Performance
11.7.4. Recent Initiatives
11.8. Sanofi
11.8.1. Company Overview
11.8.2. Product Offerings
11.8.3. Financial Performance
11.8.4. Recent Initiatives
11.9. Tandem Diabetes Care, Inc.
11.9.1. Company Overview
11.9.2. Product Offerings
11.9.3. Financial Performance
11.9.4. Recent Initiatives
11.10. Companion Medical
11.10.1. Company Overview
11.10.2. Product Offerings
11.10.3. Financial Performance
11.10.4. Recent Initiatives
12.1. Primary Research
12.2. Secondary Research
12.3. Assumptions
13.1. About Us
13.2. Glossary of Terms
For questions or customization requests, please reach out to us at sales@precedenceresearch.com
No cookie-cutter, only authentic analysis – take the 1st step to become a Precedence Research client
Report Description
Get a Sample